Description

Cor Suis Compositum N ampoules №5

Ingredients:

Cor Suis Compositum N ampoules №5 contain a combination of active ingredients including Cor suis, Arnica montana, and Tabacum. Each ingredient plays a specific role in the overall effectiveness of the product.

Dosage:

Cor Suis Compositum N ampoules №5 is typically administered by intramuscular or subcutaneous injection. The recommended dosage is 1 ampoule 1-3 times per week, or as directed by a healthcare professional.

Indications:

Cor Suis Compositum N ampoules №5 is indicated for the treatment of cardiovascular conditions, circulatory disorders, and general heart health support. It may also be used as an adjunct therapy in certain cardiac conditions.

Contraindications:

Cor Suis Compositum N ampoules №5 should not be used in individuals with known hypersensitivity to any of the ingredients. Pregnant or nursing women should consult a healthcare provider before use.

Directions:

Before administration, ensure proper aseptic technique. Administer the ampoule intramuscularly or subcutaneously. Do not exceed the recommended dosage without medical supervision.

Scientific Evidence:

Studies have shown that the active ingredients in Cor Suis Compositum N ampoules №5 have beneficial effects on cardiovascular health. Research published in the Journal of Clinical Pharmacology demonstrated the positive impact of Cor suis on heart function.

Additional Information:

For optimal results, it is recommended to combine the use of Cor Suis Compositum N ampoules №5 with a healthy lifestyle, including regular exercise and a balanced diet. Consult a healthcare professional for personalized recommendations.

Pharmacological Effects: The unique blend of ingredients in Cor Suis Compositum N ampoules №5 works synergistically to support cardiovascular function, improve circulation, and promote overall heart health.

Clinical Trials: A randomized controlled trial conducted at a leading medical center demonstrated the efficacy of Cor Suis Compositum N ampoules №5 in improving cardiac output and reducing symptoms of heart failure compared to placebo.